Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process
We report a female patient with Gaucher disease (GD) type I on ERT (imiglucerase) for 5 years, which led to a significant general improvement. Aged 59 years she underwent an episode of altitude sickness followed by sepsis, disseminated intravascular coagulation, and multiorgan failure. She succumbed...
Gespeichert in:
Veröffentlicht in: | Journal of inherited metabolic disease 2009-08, Vol.32 (4), p.551-559 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 559 |
---|---|
container_issue | 4 |
container_start_page | 551 |
container_title | Journal of inherited metabolic disease |
container_volume | 32 |
creator | Hůlková, H Ledvinová, J Poupětová, H Kohout, A Malinová, V Elleder, M |
description | We report a female patient with Gaucher disease (GD) type I on ERT (imiglucerase) for 5 years, which led to a significant general improvement. Aged 59 years she underwent an episode of altitude sickness followed by sepsis, disseminated intravascular coagulation, and multiorgan failure. She succumbed to a cerebral haemorrhage. Autopsy revealed liver cholestatic cirrhosis and multifocal liver carcinoma with immunophenotype compatible with cholangiocarcinoma. Analysis of the storage process revealed its absence or very low levels in the majority of liver and spleen macrophages. Gaucher cells (GCs) were seen only as occasional aggregates of various sizes in these organs. GCs were seen also in the leptomeninx of the cerebellum and as infrequent perivascular clusters in both the grey and white cerebral matters. Bone marrow was heavily infiltrated with GCs, especially in the adipocyte-rich part. GCs in this location displayed varied degrees of cytoplasmic vacuolation unrelated to the lysosomal compartment, caused by droplets of triglyceride, and interpreted as due to resorption of fragments of altered white adipocytes. All these observations point to the relative efficacy of ERT in covering the standard substrate load, which should not be exceeded as it would lead to the evolution of mature GCs. The results are discussed in relation to our recently published hypothesis on GD cell pathology. |
doi_str_mv | 10.1007/s10545-009-1178-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_746151104</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67585667</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5031-a0f0ee88b18147235f95926301b3c3d55947b1ee668152c0aa1bb5789d14fa893</originalsourceid><addsrcrecordid>eNqFkc1u1EAQhC0EIpvAA3CBERJwcpi2PX_HaIGwKIgD5Dwaz7YXR_7LtC1k3iBvzVheEYlDOLVU-qqrW5UkL4CfA-fqPQEXhUg5NymA0ql5lGxAqDzNpBSPkw2HAlJthDhJTolueAS1EE-TE4iaitZNcncxjf1AM_OOkPUVu3ST_4mB7WvCRRrnAdmO1R1zbHBjjd3I-o5h93tukQUcGuexXdQx2twwn7Nt3y4CLVwU2X7uXFt7WtYPGKimceFp7IM7IBtC75HoWfKkcg3h8-M8S64_ffyx_ZxefbvcbS-uUi94DqnjFUfUugQNhcpyURlhMplzKHOf74UwhSoBUUoNIvPcOShLobTZQ1E5bfKz5N26N-beTkijbWvy2DSuw34iqwoJAoAXkXz7ICmV0EJKFcHX_4A3_RS6-IXNQOtCS84jBCvkQ08UsLJDqFsXZgvcLnXatU4bW7JLnXa59eVx8VS2uL93HPuLwJsj4Mi7pgqu8zX95WJ6bjJYwtXK_aobnP-fbL_svn7gQkB0ZquToqk7YLj_7aG7X62myvXWHUI86fp7xiG2JKU0psj_AK5P0O8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>218848600</pqid></control><display><type>article</type><title>Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process</title><source>MEDLINE</source><source>Wiley Journals</source><source>SpringerLink Journals - AutoHoldings</source><creator>Hůlková, H ; Ledvinová, J ; Poupětová, H ; Kohout, A ; Malinová, V ; Elleder, M</creator><creatorcontrib>Hůlková, H ; Ledvinová, J ; Poupětová, H ; Kohout, A ; Malinová, V ; Elleder, M</creatorcontrib><description>We report a female patient with Gaucher disease (GD) type I on ERT (imiglucerase) for 5 years, which led to a significant general improvement. Aged 59 years she underwent an episode of altitude sickness followed by sepsis, disseminated intravascular coagulation, and multiorgan failure. She succumbed to a cerebral haemorrhage. Autopsy revealed liver cholestatic cirrhosis and multifocal liver carcinoma with immunophenotype compatible with cholangiocarcinoma. Analysis of the storage process revealed its absence or very low levels in the majority of liver and spleen macrophages. Gaucher cells (GCs) were seen only as occasional aggregates of various sizes in these organs. GCs were seen also in the leptomeninx of the cerebellum and as infrequent perivascular clusters in both the grey and white cerebral matters. Bone marrow was heavily infiltrated with GCs, especially in the adipocyte-rich part. GCs in this location displayed varied degrees of cytoplasmic vacuolation unrelated to the lysosomal compartment, caused by droplets of triglyceride, and interpreted as due to resorption of fragments of altered white adipocytes. All these observations point to the relative efficacy of ERT in covering the standard substrate load, which should not be exceeded as it would lead to the evolution of mature GCs. The results are discussed in relation to our recently published hypothesis on GD cell pathology.</description><identifier>ISSN: 0141-8955</identifier><identifier>EISSN: 1573-2665</identifier><identifier>DOI: 10.1007/s10545-009-1178-9</identifier><identifier>PMID: 19557545</identifier><identifier>CODEN: JIMDDP</identifier><language>eng</language><publisher>Dordrecht: Dordrecht : Springer Netherlands</publisher><subject>Autopsy ; Biochemistry ; Biological and medical sciences ; Biological Transport, Active - physiology ; Errors of metabolism ; Female ; Gaucher Disease - drug therapy ; Gaucher Disease - metabolism ; Gaucher Disease - pathology ; Glucosylceramidase - therapeutic use ; Human Genetics ; Humans ; Internal Medicine ; Lipids (lysosomal enzyme disorders, storage diseases) ; Medical genetics ; Medical sciences ; Medicine ; Medicine & Public Health ; Metabolic Diseases ; Middle Aged ; Original Article ; Pediatrics ; Recombinant Proteins - therapeutic use</subject><ispartof>Journal of inherited metabolic disease, 2009-08, Vol.32 (4), p.551-559</ispartof><rights>Springer Science+Business Media B.V. 2009</rights><rights>2009 SSIEM</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5031-a0f0ee88b18147235f95926301b3c3d55947b1ee668152c0aa1bb5789d14fa893</citedby><cites>FETCH-LOGICAL-c5031-a0f0ee88b18147235f95926301b3c3d55947b1ee668152c0aa1bb5789d14fa893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10545-009-1178-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10545-009-1178-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,41488,42557,45574,45575,51319</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21839210$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19557545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hůlková, H</creatorcontrib><creatorcontrib>Ledvinová, J</creatorcontrib><creatorcontrib>Poupětová, H</creatorcontrib><creatorcontrib>Kohout, A</creatorcontrib><creatorcontrib>Malinová, V</creatorcontrib><creatorcontrib>Elleder, M</creatorcontrib><title>Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process</title><title>Journal of inherited metabolic disease</title><addtitle>J Inherit Metab Dis</addtitle><addtitle>J Inherit Metab Dis</addtitle><description>We report a female patient with Gaucher disease (GD) type I on ERT (imiglucerase) for 5 years, which led to a significant general improvement. Aged 59 years she underwent an episode of altitude sickness followed by sepsis, disseminated intravascular coagulation, and multiorgan failure. She succumbed to a cerebral haemorrhage. Autopsy revealed liver cholestatic cirrhosis and multifocal liver carcinoma with immunophenotype compatible with cholangiocarcinoma. Analysis of the storage process revealed its absence or very low levels in the majority of liver and spleen macrophages. Gaucher cells (GCs) were seen only as occasional aggregates of various sizes in these organs. GCs were seen also in the leptomeninx of the cerebellum and as infrequent perivascular clusters in both the grey and white cerebral matters. Bone marrow was heavily infiltrated with GCs, especially in the adipocyte-rich part. GCs in this location displayed varied degrees of cytoplasmic vacuolation unrelated to the lysosomal compartment, caused by droplets of triglyceride, and interpreted as due to resorption of fragments of altered white adipocytes. All these observations point to the relative efficacy of ERT in covering the standard substrate load, which should not be exceeded as it would lead to the evolution of mature GCs. The results are discussed in relation to our recently published hypothesis on GD cell pathology.</description><subject>Autopsy</subject><subject>Biochemistry</subject><subject>Biological and medical sciences</subject><subject>Biological Transport, Active - physiology</subject><subject>Errors of metabolism</subject><subject>Female</subject><subject>Gaucher Disease - drug therapy</subject><subject>Gaucher Disease - metabolism</subject><subject>Gaucher Disease - pathology</subject><subject>Glucosylceramidase - therapeutic use</subject><subject>Human Genetics</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Lipids (lysosomal enzyme disorders, storage diseases)</subject><subject>Medical genetics</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolic Diseases</subject><subject>Middle Aged</subject><subject>Original Article</subject><subject>Pediatrics</subject><subject>Recombinant Proteins - therapeutic use</subject><issn>0141-8955</issn><issn>1573-2665</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkc1u1EAQhC0EIpvAA3CBERJwcpi2PX_HaIGwKIgD5Dwaz7YXR_7LtC1k3iBvzVheEYlDOLVU-qqrW5UkL4CfA-fqPQEXhUg5NymA0ql5lGxAqDzNpBSPkw2HAlJthDhJTolueAS1EE-TE4iaitZNcncxjf1AM_OOkPUVu3ST_4mB7WvCRRrnAdmO1R1zbHBjjd3I-o5h93tukQUcGuexXdQx2twwn7Nt3y4CLVwU2X7uXFt7WtYPGKimceFp7IM7IBtC75HoWfKkcg3h8-M8S64_ffyx_ZxefbvcbS-uUi94DqnjFUfUugQNhcpyURlhMplzKHOf74UwhSoBUUoNIvPcOShLobTZQ1E5bfKz5N26N-beTkijbWvy2DSuw34iqwoJAoAXkXz7ICmV0EJKFcHX_4A3_RS6-IXNQOtCS84jBCvkQ08UsLJDqFsXZgvcLnXatU4bW7JLnXa59eVx8VS2uL93HPuLwJsj4Mi7pgqu8zX95WJ6bjJYwtXK_aobnP-fbL_svn7gQkB0ZquToqk7YLj_7aG7X62myvXWHUI86fp7xiG2JKU0psj_AK5P0O8</recordid><startdate>200908</startdate><enddate>200908</enddate><creator>Hůlková, H</creator><creator>Ledvinová, J</creator><creator>Poupětová, H</creator><creator>Kohout, A</creator><creator>Malinová, V</creator><creator>Elleder, M</creator><general>Dordrecht : Springer Netherlands</general><general>Springer Netherlands</general><general>Springer</general><general>Blackwell Publishing Ltd</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>200908</creationdate><title>Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process</title><author>Hůlková, H ; Ledvinová, J ; Poupětová, H ; Kohout, A ; Malinová, V ; Elleder, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5031-a0f0ee88b18147235f95926301b3c3d55947b1ee668152c0aa1bb5789d14fa893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Autopsy</topic><topic>Biochemistry</topic><topic>Biological and medical sciences</topic><topic>Biological Transport, Active - physiology</topic><topic>Errors of metabolism</topic><topic>Female</topic><topic>Gaucher Disease - drug therapy</topic><topic>Gaucher Disease - metabolism</topic><topic>Gaucher Disease - pathology</topic><topic>Glucosylceramidase - therapeutic use</topic><topic>Human Genetics</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Lipids (lysosomal enzyme disorders, storage diseases)</topic><topic>Medical genetics</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolic Diseases</topic><topic>Middle Aged</topic><topic>Original Article</topic><topic>Pediatrics</topic><topic>Recombinant Proteins - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hůlková, H</creatorcontrib><creatorcontrib>Ledvinová, J</creatorcontrib><creatorcontrib>Poupětová, H</creatorcontrib><creatorcontrib>Kohout, A</creatorcontrib><creatorcontrib>Malinová, V</creatorcontrib><creatorcontrib>Elleder, M</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Journal of inherited metabolic disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hůlková, H</au><au>Ledvinová, J</au><au>Poupětová, H</au><au>Kohout, A</au><au>Malinová, V</au><au>Elleder, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process</atitle><jtitle>Journal of inherited metabolic disease</jtitle><stitle>J Inherit Metab Dis</stitle><addtitle>J Inherit Metab Dis</addtitle><date>2009-08</date><risdate>2009</risdate><volume>32</volume><issue>4</issue><spage>551</spage><epage>559</epage><pages>551-559</pages><issn>0141-8955</issn><eissn>1573-2665</eissn><coden>JIMDDP</coden><abstract>We report a female patient with Gaucher disease (GD) type I on ERT (imiglucerase) for 5 years, which led to a significant general improvement. Aged 59 years she underwent an episode of altitude sickness followed by sepsis, disseminated intravascular coagulation, and multiorgan failure. She succumbed to a cerebral haemorrhage. Autopsy revealed liver cholestatic cirrhosis and multifocal liver carcinoma with immunophenotype compatible with cholangiocarcinoma. Analysis of the storage process revealed its absence or very low levels in the majority of liver and spleen macrophages. Gaucher cells (GCs) were seen only as occasional aggregates of various sizes in these organs. GCs were seen also in the leptomeninx of the cerebellum and as infrequent perivascular clusters in both the grey and white cerebral matters. Bone marrow was heavily infiltrated with GCs, especially in the adipocyte-rich part. GCs in this location displayed varied degrees of cytoplasmic vacuolation unrelated to the lysosomal compartment, caused by droplets of triglyceride, and interpreted as due to resorption of fragments of altered white adipocytes. All these observations point to the relative efficacy of ERT in covering the standard substrate load, which should not be exceeded as it would lead to the evolution of mature GCs. The results are discussed in relation to our recently published hypothesis on GD cell pathology.</abstract><cop>Dordrecht</cop><pub>Dordrecht : Springer Netherlands</pub><pmid>19557545</pmid><doi>10.1007/s10545-009-1178-9</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0141-8955 |
ispartof | Journal of inherited metabolic disease, 2009-08, Vol.32 (4), p.551-559 |
issn | 0141-8955 1573-2665 |
language | eng |
recordid | cdi_proquest_miscellaneous_746151104 |
source | MEDLINE; Wiley Journals; SpringerLink Journals - AutoHoldings |
subjects | Autopsy Biochemistry Biological and medical sciences Biological Transport, Active - physiology Errors of metabolism Female Gaucher Disease - drug therapy Gaucher Disease - metabolism Gaucher Disease - pathology Glucosylceramidase - therapeutic use Human Genetics Humans Internal Medicine Lipids (lysosomal enzyme disorders, storage diseases) Medical genetics Medical sciences Medicine Medicine & Public Health Metabolic Diseases Middle Aged Original Article Pediatrics Recombinant Proteins - therapeutic use |
title | Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T03%3A46%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Autopsy%20case%20of%20Gaucher%20disease%20type%20I%20in%20a%20patient%20on%20enzyme%20replacement%20therapy.%20Comments%20on%20the%20dynamics%20of%20persistent%20storage%20process&rft.jtitle=Journal%20of%20inherited%20metabolic%20disease&rft.au=H%C5%AFlkov%C3%A1,%20H&rft.date=2009-08&rft.volume=32&rft.issue=4&rft.spage=551&rft.epage=559&rft.pages=551-559&rft.issn=0141-8955&rft.eissn=1573-2665&rft.coden=JIMDDP&rft_id=info:doi/10.1007/s10545-009-1178-9&rft_dat=%3Cproquest_cross%3E67585667%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=218848600&rft_id=info:pmid/19557545&rfr_iscdi=true |